Latest Cryoport Inc (CYRX) Headlines
10-Q: CRYOPORT, INC.
Edgar Online - Thu Feb 13, 12:05PM CST
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
Cryoport Increases Revenues By 149% For The First Nine Months of Fiscal 2014
Business Wire - Thu Feb 13, 5:00AM CST
Cryoport, Inc. (OTCBB: CYRX) today announced financial results for the quarter and nine months ended December 31, 2013.
Liventa Bioscience and Cryoport Form Alliance to Deliver Cell-Based Biologics to Point-of-Service Orthopedic Care
Business Wire - Wed Feb 05, 5:20PM CST
Liventa Bioscience (formerly AFcell Medical) and Cryoport, Inc. (OTC:CYRX) today announced a major strategic alliance aimed at serving the many points of orthopedic care delivery with Liventa's cell-based, advanced biologics tissue forms. The exclusive agreement combines Cryoport's proprietary, purpose-built cold chain logistics solutions for cell-based and advanced biologic tissue forms with Liventa Bioscience's distribution capability to "point-of-use" US-based orthopedic care providers.
Liventa Bioscience and Cryoport form Alliance to deliver cell-based biologics to Point-of-Service Orthopedic Care
PR Newswire - Wed Feb 05, 8:30AM CST
Liventa Bioscience (formerly AFcell Medical) and Cryoport, Inc. (OTC:CYRX) today announced a major strategic alliance aimed at serving the many points of orthopedic care delivery with Liventa's cell-based, advanced biologics tissue forms. The exclusive agreement combines Cryoport's proprietary, purpose-built cold chain logistics solutions for cell based and advanced biologic tissue forms with Liventa Bioscience's distribution capability to "point-of-use" US-based orthopedic care providers.
Cryoport Revenues Increased 151% for the First Half of Fiscal 2014
Business Wire - Mon Nov 18, 7:00AM CST
Cryoport, Inc. (OTCBB: CYRX) today announced financial results for the quarter and six months ended September 30, 2013.
Cryoport to Present at LD Micro Growth Conference on December 3, 2013
Business Wire - Fri Nov 15, 3:08PM CST
Cryoport, Inc. (OTCBB: CYRX) today announced that Chief Executive Officer Jerrell Shelton and Chief Financial Officer Robert Stefanovich are scheduled to present to investors at the 6th Annual LD Micro Growth Conference on Tuesday, December 3, 2013 at 3:00 PM PST.
Cryoport Elects Edward Zecchini to Board of Directors
Business Wire - Mon Sep 16, 7:00AM CDT
Cryoport, Inc. (OTCBB: CYRX) today announced it has elected Edward J. Zecchini to its Board of Directors. Mr. Zecchini is an established technology leader with over thirty years of experience in the healthcare and information technology industries. With this appointment, the Cryoport Board now has four members, of which three are independent directors, including Mr. Zecchini.
Cryoport Inc signs turnkey logistics solutions agreement with The World Egg Bank for shipment of human eggs
M2 - Tue Aug 20, 7:17AM CDT
Frozen shipping logistics company Cryoport Inc (OTC BB:CYRX) reported on Monday the expansion of its logistics services for reproductive medicine using its advanced turnkey logistics solution technology.
Cryoport Expands Logistics Services for Reproductive Medicine with The World Egg Bank
Business Wire - Mon Aug 19, 7:00AM CDT
Cryoport, Inc. (OTCBB: CYRX) continues its momentum as leader in advanced logistics services for reproductive medicine with The World Egg Bank (TWEB) using its advanced technology "turnkey logistics solution." Through its partnership, TWEB employs Cryoport's cloud-based logistics management software platform (known as the Cryoportal(TM)) complemented by its patented dry vapor Cryoport Express(R) Shippers and Cryoport's logistics expertise. TWEB successfully ships their critical customer products in this manner, both domestically and internationally.
Cryoport Generates Strong Interest for Its Cryogenic Logistics Solution for Reproductive Medicine
Business Wire - Thu Aug 15, 7:00AM CDT
Cryoport, Inc. (OTCBB: CYRX) recently showcased its Cryoport Express(R) logistics solutions during the 29th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) in London. This critical meeting was the kickoff for Cryoport's expanded presence within the EU reproductive medicine arena.
Cryoport and Zoetis Expand Cold Chain Logistics Relationship
Business Wire - Mon Jul 22, 11:06AM CDT
Cryoport, Inc. (OTCBB: CYRX) today announced that it has reached agreement with Zoetis Inc. (formerly the animal health business unit of Pfizer Inc.) to expand the scope of the cold chain logistics services Cryoport is providing.
Cryoport Inc doubles revenues to USD1.1m in fiscal 2013, with sales growth continueing to increase in fiscal 2014
M2 - Fri Jun 07, 4:59AM CDT
Frozen shipping logistics company Cryoport Inc (OTC BB:CYRX) reported on Thursday a net loss of USD6.4m for the fiscal year ended 31 March 2013.
Cryoport Doubles Revenues for Fiscal 2013
Business Wire - Thu Jun 06, 7:00AM CDT
Cryoport, Inc. (OTCBB: CYRX) today announced preliminary financial results for the fiscal fourth quarter and year ended March 31, 2013. Revenues for fiscal 2013 were $1.1 million, an increase of 98%, compared with revenues of $556,000 in fiscal 2012. Operating expenses in fiscal 2013 were $5.8 million, down 12%, compared with operating expenses of $6.6 million in fiscal 2012. Excluding stock-based expenses, operating expenses in fiscal 2013 were $5.1 million, down 15%, compared with $6.0 million in fiscal 2012. The net loss in fiscal 2013 was $6.4 million, compared with a net loss of $7.8 million in fiscal 2012.
Cryoport Appoints Richard Rathmann to Board of Directors
Business Wire - Mon Apr 01, 7:00AM CDT
Cryoport, Inc. (OTCBB: CYRX) today announced it has appointed Richard G. Rathmann to its Board of Directors. Mr. Rathmann is an experienced venture fund manager and advisor to life science companies. With this appointment, the Cryoport Board now has five members, of which four are considered independent directors, including Mr. Rathmann.
Cryoport to Provide Full Range of Deep Frozen Shipping and Logistics Services to Clinical Reference Laboratory
Business Wire - Mon Jan 14, 7:00AM CST
Cryoport, Inc. (OTCBB: CYRX) today announced that it is expanding its services to Clinical Reference Laboratory (CRL) for the transportation of high-value test samples and specimens. CRL is a leading provider of testing services for clinical trials, molecular diagnostics and toxicology.
Cryoport Inc adds Bill Taaffe to CAB
M2 - Tue Jan 08, 7:13AM CST
Frozen shipping logistics company Cryoport Inc (OTC BB :CYRX) stated on Monday that Bill Taaffe has been selected as a member of its newly formed Commercial Advisory Board (CAB).
Cryoport Appoints Bill Taaffe to Commercial Advisory Board
Business Wire - Mon Jan 07, 7:00AM CST
Cryoport, Inc. (OTCBB: CYRX) today announced it has named Bill Taaffe as a member of its newly formed Commercial Advisory Board (CAB). Mr. Taaffe was a founding member of ICON Clinical Research, and during his 18 years with the firm held the position of President and Chief Executive Officer, North America, prior to retiring in 2011. ICON is a leading global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. He has more than 40 years of experience in the pharmaceutical and clinical research industries, including serving as Chief Executive Officer, USA, of The Institute of Clinical Pharmacology.
Cryoport to Present at the Biotech Showcase on January 7
Business Wire - Wed Jan 02, 7:00AM CST
Cryoport, Inc. (OTCBB:CYRX) today announced that Chief Executive Officer Jerrell Shelton is scheduled to present at the Biotech Showcase on Monday, January 7, 2013 at 9:00 a.m. Pacific time. The conference is being held in San Francisco at the Parc 55 Wyndham Union Square Hotel.
10-Q: CRYOPORT, INC.
Edgar Online - Thu Feb 13, 12:05PM CST
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
Cryoport Increases Revenues By 149% For The First Nine Months of Fiscal 2014
Business Wire - Thu Feb 13, 5:00AM CST
Cryoport, Inc. (OTCBB: CYRX) today announced financial results for the quarter and nine months ended December 31, 2013.
Liventa Bioscience and Cryoport Form Alliance to Deliver Cell-Based Biologics to Point-of-Service Orthopedic Care
Business Wire - Wed Feb 05, 5:20PM CST
Liventa Bioscience (formerly AFcell Medical) and Cryoport, Inc. (OTC:CYRX) today announced a major strategic alliance aimed at serving the many points of orthopedic care delivery with Liventa's cell-based, advanced biologics tissue forms. The exclusive agreement combines Cryoport's proprietary, purpose-built cold chain logistics solutions for cell-based and advanced biologic tissue forms with Liventa Bioscience's distribution capability to "point-of-use" US-based orthopedic care providers.
Liventa Bioscience and Cryoport form Alliance to deliver cell-based biologics to Point-of-Service Orthopedic Care
PR Newswire - Wed Feb 05, 8:30AM CST
Liventa Bioscience (formerly AFcell Medical) and Cryoport, Inc. (OTC:CYRX) today announced a major strategic alliance aimed at serving the many points of orthopedic care delivery with Liventa's cell-based, advanced biologics tissue forms. The exclusive agreement combines Cryoport's proprietary, purpose-built cold chain logistics solutions for cell based and advanced biologic tissue forms with Liventa Bioscience's distribution capability to "point-of-use" US-based orthopedic care providers.
Cryoport Revenues Increased 151% for the First Half of Fiscal 2014
Business Wire - Mon Nov 18, 7:00AM CST
Cryoport, Inc. (OTCBB: CYRX) today announced financial results for the quarter and six months ended September 30, 2013.
Cryoport to Present at LD Micro Growth Conference on December 3, 2013
Business Wire - Fri Nov 15, 3:08PM CST
Cryoport, Inc. (OTCBB: CYRX) today announced that Chief Executive Officer Jerrell Shelton and Chief Financial Officer Robert Stefanovich are scheduled to present to investors at the 6th Annual LD Micro Growth Conference on Tuesday, December 3, 2013 at 3:00 PM PST.
Cryoport Elects Edward Zecchini to Board of Directors
Business Wire - Mon Sep 16, 7:00AM CDT
Cryoport, Inc. (OTCBB: CYRX) today announced it has elected Edward J. Zecchini to its Board of Directors. Mr. Zecchini is an established technology leader with over thirty years of experience in the healthcare and information technology industries. With this appointment, the Cryoport Board now has four members, of which three are independent directors, including Mr. Zecchini.
Cryoport Inc signs turnkey logistics solutions agreement with The World Egg Bank for shipment of human eggs
M2 - Tue Aug 20, 7:17AM CDT
Frozen shipping logistics company Cryoport Inc (OTC BB:CYRX) reported on Monday the expansion of its logistics services for reproductive medicine using its advanced turnkey logistics solution technology.
Cryoport Expands Logistics Services for Reproductive Medicine with The World Egg Bank
Business Wire - Mon Aug 19, 7:00AM CDT
Cryoport, Inc. (OTCBB: CYRX) continues its momentum as leader in advanced logistics services for reproductive medicine with The World Egg Bank (TWEB) using its advanced technology "turnkey logistics solution." Through its partnership, TWEB employs Cryoport's cloud-based logistics management software platform (known as the Cryoportal(TM)) complemented by its patented dry vapor Cryoport Express(R) Shippers and Cryoport's logistics expertise. TWEB successfully ships their critical customer products in this manner, both domestically and internationally.
Cryoport Generates Strong Interest for Its Cryogenic Logistics Solution for Reproductive Medicine
Business Wire - Thu Aug 15, 7:00AM CDT
Cryoport, Inc. (OTCBB: CYRX) recently showcased its Cryoport Express(R) logistics solutions during the 29th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) in London. This critical meeting was the kickoff for Cryoport's expanded presence within the EU reproductive medicine arena.
Cryoport and Zoetis Expand Cold Chain Logistics Relationship
Business Wire - Mon Jul 22, 11:06AM CDT
Cryoport, Inc. (OTCBB: CYRX) today announced that it has reached agreement with Zoetis Inc. (formerly the animal health business unit of Pfizer Inc.) to expand the scope of the cold chain logistics services Cryoport is providing.
Cryoport Inc doubles revenues to USD1.1m in fiscal 2013, with sales growth continueing to increase in fiscal 2014
M2 - Fri Jun 07, 4:59AM CDT
Frozen shipping logistics company Cryoport Inc (OTC BB:CYRX) reported on Thursday a net loss of USD6.4m for the fiscal year ended 31 March 2013.
Cryoport Doubles Revenues for Fiscal 2013
Business Wire - Thu Jun 06, 7:00AM CDT
Cryoport, Inc. (OTCBB: CYRX) today announced preliminary financial results for the fiscal fourth quarter and year ended March 31, 2013. Revenues for fiscal 2013 were $1.1 million, an increase of 98%, compared with revenues of $556,000 in fiscal 2012. Operating expenses in fiscal 2013 were $5.8 million, down 12%, compared with operating expenses of $6.6 million in fiscal 2012. Excluding stock-based expenses, operating expenses in fiscal 2013 were $5.1 million, down 15%, compared with $6.0 million in fiscal 2012. The net loss in fiscal 2013 was $6.4 million, compared with a net loss of $7.8 million in fiscal 2012.
Cryoport Appoints Richard Rathmann to Board of Directors
Business Wire - Mon Apr 01, 7:00AM CDT
Cryoport, Inc. (OTCBB: CYRX) today announced it has appointed Richard G. Rathmann to its Board of Directors. Mr. Rathmann is an experienced venture fund manager and advisor to life science companies. With this appointment, the Cryoport Board now has five members, of which four are considered independent directors, including Mr. Rathmann.
Cryoport to Provide Full Range of Deep Frozen Shipping and Logistics Services to Clinical Reference Laboratory
Business Wire - Mon Jan 14, 7:00AM CST
Cryoport, Inc. (OTCBB: CYRX) today announced that it is expanding its services to Clinical Reference Laboratory (CRL) for the transportation of high-value test samples and specimens. CRL is a leading provider of testing services for clinical trials, molecular diagnostics and toxicology.
Cryoport Inc adds Bill Taaffe to CAB
M2 - Tue Jan 08, 7:13AM CST
Frozen shipping logistics company Cryoport Inc (OTC BB :CYRX) stated on Monday that Bill Taaffe has been selected as a member of its newly formed Commercial Advisory Board (CAB).
Cryoport Appoints Bill Taaffe to Commercial Advisory Board
Business Wire - Mon Jan 07, 7:00AM CST
Cryoport, Inc. (OTCBB: CYRX) today announced it has named Bill Taaffe as a member of its newly formed Commercial Advisory Board (CAB). Mr. Taaffe was a founding member of ICON Clinical Research, and during his 18 years with the firm held the position of President and Chief Executive Officer, North America, prior to retiring in 2011. ICON is a leading global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. He has more than 40 years of experience in the pharmaceutical and clinical research industries, including serving as Chief Executive Officer, USA, of The Institute of Clinical Pharmacology.
Cryoport to Present at the Biotech Showcase on January 7
Business Wire - Wed Jan 02, 7:00AM CST
Cryoport, Inc. (OTCBB:CYRX) today announced that Chief Executive Officer Jerrell Shelton is scheduled to present at the Biotech Showcase on Monday, January 7, 2013 at 9:00 a.m. Pacific time. The conference is being held in San Francisco at the Parc 55 Wyndham Union Square Hotel.
